Authors
Loading...
Real-world study shows ctDNA changes predict clinical outcomes in patients treated with immune checkpoint inhibitors, indicating better assessment methods.
Liang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: